Dominika Szkopek
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Dominika Szkopek has a total of 108 co-authors. Here are the top co-authors by number of shared publications:
- Jarosław Woliński
Large Animal Models Laboratory, The Kielanowski Institute of Animal Physiology and Nutrition, Polish Academy of Sciences, 05-110 Jabłonna, Poland
9 shared publications - Kamil Zaworski
Department of Animal Physiology, The Kielanowski Institute of Animal Physiology and Nutrition, Polish Academy of Sciences, 05-110 Jabłonna, Poland
8 shared publications - Paweł Konieczka
Department of Poultry Science and Apiculture, University of Warmia and Mazury in Olsztyn, Oczapowskiego St. 5, 10-719 Olsztyn, Poland
8 shared publications - Janine Donaldson
School of Physiology, Faculty of Health Sciences, University of the Witwatersrand, Parktown, Johannesburg 2193, South Africa
7 shared publications - Kateryna Pierzynowska
Department of Animal Physiology, The Kielanowski Institute of Animal Physiology and Nutrition, Polish Academy of Sciences, Instytucka 3, 05-110 Jabłonna, Poland
7 shared publications - Stefan Grzegorz Pierzynowski
Department of Biology, Lund University, Lund, Sweden
5 shared publications
Latest Publications
- Open Access
- 29 October 2026
- Published by MDPI AG in Preprints.org
Effect of Meat from Chickens Fed Diets Supplemented with Selenium Nanoparticles or Cannabidiol on the Health Status of Rats
Background/Objectives: Selenium nanoparticles (SeNPs) and cannabidiol (CBD) supplementation may alter chicken meat composition. This study investigated health indicators in rats consuming meat from chickens fed SeNPs-, and/or CBD-supplemented diets. Methods: Forty male rats received for 10 weeks a control diet without chicken meat or diets containing 24% meat from chickens supplemented with sodium selenate, SeNPs, CBD, or both. Body weight, fat mass, fecal calprotectin, hematological and biochemical parameters, and gene expression in epididymal white adipose tissue were measured. Results: Neither body weight nor fat mass differed significantly (P > 0.05). In the SeNPs and CBD groups, genes expressions of fatty acid synthase (FASN), solute carrier family 2 member 4 (SLC2A4), glucose transporter type 4 (GLUT4), lipoprotein lipase (LPL), and protein kinase AMP-activated catalytic subunit alpha 2 (PRKAA2) genes were lower than in control and the sodium selenate group (P<0.05). Fecal calprotectin was highest in the SeNPs/CBD group (p < 0.001). Blood hematological and biochemical indices did not show health disorders in rats fed experimental diets. Conclusions: The results indicate that following the enrichment of broiler chicken meat with selenium and/or CBD through dietary supplementation resulted that when being used in the chicken diets, they were well tolerated and did not adversely affect their health status, as evaluated based on the analyzed parameters and indicators. These findings provide valuable data that may contribute to the assessment of the safety of SeNPs and CBD in chicken nutrition and legislative regulations.
- 29 October 2026
- Published by MDPI AG in Preprints.org
Open AccessEffect of Meat from Chickens Fed Diets Supplemented with Selenium Nanoparticles or Cannabidiol on the Health Status of Rats
Background/Objectives: Selenium nanoparticles (SeNPs) and cannabidiol (CBD) supplementation may alter chicken meat composition. This study investigated health indicators in rats consuming meat from chickens fed SeNPs-, and/or CBD-supplemented diets. Methods: Forty male rats received for 10 weeks a control diet without chicken meat or diets containing 24% meat from chickens supplemented with sodium selenate, SeNPs, CBD, or both. Body weight, fat mass, fecal calprotectin, hematological and biochemical parameters, and gene expression in epididymal white adipose tissue were measured. Results: Neither body weight nor fat mass differed significantly (P > 0.05). In the SeNPs and CBD groups, genes expressions of fatty acid synthase (FASN), solute carrier family 2 member 4 (SLC2A4), glucose transporter type 4 (GLUT4), lipoprotein lipase (LPL), and protein kinase AMP-activated catalytic subunit alpha 2 (PRKAA2) genes were lower than in control and the sodium selenate group (P<0.05). Fecal calprotectin was highest in the SeNPs/CBD group (p < 0.001). Blood hematological and biochemical indices did not show health disorders in rats fed experimental diets. Conclusions: The results indicate that following the enrichment of broiler chicken meat with selenium and/or CBD through dietary supplementation resulted that when being used in the chicken diets, they were well tolerated and did not adversely affect their health status, as evaluated based on the analyzed parameters and indicators. These findings provide valuable data that may contribute to the assessment of the safety of SeNPs and CBD in chicken nutrition and legislative regulations.
- Open Access
- 3 September 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (17) , 7885
Animal Models of Hyperoxaluria and Their Relevance for Fundamental Research and Clinical Practice
In vivo models have been central to understanding hyperoxaluria pathogenesis and to the development of emerging therapeutic strategies, but no single model fully reproduces the complexity of human disease. This narrative review critically evaluates currently available in vivo models of hyperoxaluria and provides a framework for their selection, interpretation, and integration according to the specific phenotype and biological or therapeutic question under investigation. A structured, non-systematic literature search was conducted in PubMed, Web of Science, Scopus, and Google Scholar, with emphasis on peer-reviewed primary studies and relevant reviews addressing experimental models, disease mechanisms, and therapeutic interventions. Chemically and dietary induced, genetic, enteric and microbial, and large-animal models were evaluated with respect to model validity, experimental endpoints, pathophysiological relevance, and translational potential. A central feature of this review is the distinction between related but non-interchangeable phenotypes, including hyperoxaluria, crystalluria, nephrocalcinosis, oxalate nephropathy, and nephrolithiasis. This distinction provides the conceptual basis for comparing models that reproduce different stages or consequences of oxalate exposure rather than treating all calcium oxalate-associated phenotypes as equivalent. Chemically induced models are particularly useful for studying hyperoxaluria, calcium oxalate crystallization, and acute or subacute renal injury, whereas genetic models reproduce specific molecular defects underlying primary hyperoxaluria and support the development of mechanism-based therapies. Enteric and microbial models address intestinal oxalate handling and the gut–kidney axis and are particularly relevant for investigating gut-directed therapeutic strategies. Naturally occurring models may provide complementary insight into chronic clinical phenotypes, whereas large-animal models can facilitate selected translational and experimentally intensive investigations. The reviewed evidence demonstrates that no model can be considered superior. Instead, model selection should be guided by the specific mechanism, phenotype, or therapeutic intervention under investigation. This review therefore proposes a phenotype-oriented and question-driven framework for model selection and interpretation, taking into consideration validity, reproducibility, ethical aspects, and the limits of translational extrapolation.
- 3 September 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (17) , 7885
Open AccessAnimal Models of Hyperoxaluria and Their Relevance for Fundamental Research and Clinical Practice
In vivo models have been central to understanding hyperoxaluria pathogenesis and to the development of emerging therapeutic strategies, but no single model fully reproduces the complexity of human disease. This narrative review critically evaluates currently available in vivo models of hyperoxaluria and provides a framework for their selection, interpretation, and integration according to the specific phenotype and biological or therapeutic question under investigation. A structured, non-systematic literature search was conducted in PubMed, Web of Science, Scopus, and Google Scholar, with emphasis on peer-reviewed primary studies and relevant reviews addressing experimental models, disease mechanisms, and therapeutic interventions. Chemically and dietary induced, genetic, enteric and microbial, and large-animal models were evaluated with respect to model validity, experimental endpoints, pathophysiological relevance, and translational potential. A central feature of this review is the distinction between related but non-interchangeable phenotypes, including hyperoxaluria, crystalluria, nephrocalcinosis, oxalate nephropathy, and nephrolithiasis. This distinction provides the conceptual basis for comparing models that reproduce different stages or consequences of oxalate exposure rather than treating all calcium oxalate-associated phenotypes as equivalent. Chemically induced models are particularly useful for studying hyperoxaluria, calcium oxalate crystallization, and acute or subacute renal injury, whereas genetic models reproduce specific molecular defects underlying primary hyperoxaluria and support the development of mechanism-based therapies. Enteric and microbial models address intestinal oxalate handling and the gut–kidney axis and are particularly relevant for investigating gut-directed therapeutic strategies. Naturally occurring models may provide complementary insight into chronic clinical phenotypes, whereas large-animal models can facilitate selected translational and experimentally intensive investigations. The reviewed evidence demonstrates that no model can be considered superior. Instead, model selection should be guided by the specific mechanism, phenotype, or therapeutic intervention under investigation. This review therefore proposes a phenotype-oriented and question-driven framework for model selection and interpretation, taking into consideration validity, reproducibility, ethical aspects, and the limits of translational extrapolation.
- Open Access
- 4 June 2026
- Published by IOP Publishing in Biofabrication
- Vol. 18 (3) , 035017
A Preclinical Large-Animal Evaluation of a 3D Bioprinted Bionic Pancreatic Tissue Model Built on Simplified Vascular Architecture
Three-dimensional (3D) bioprinting enables the fabrication of complex tissue constructs with integrated vascular architectures, offering promising applications in transplantation. It is commonly assumed that dense, pre-formed microvascular networks are required to ensure survival and function of bioprinted organs immediately after implantation. This in vivo study aimed to evaluate the feasibility of bioprinting and transplanting a vascularized pancreatic tissue construct featuring a single perfusable vessel in a porcine model, with a focus on maintaining stable perfusion and supporting post-transplantation microvascular development. The study included 14 pigs, in which a 3D-bioprinted construct was transplanted and connected to the iliac artery or abdominal aorta. Two vascular connection strategies were evaluated: the Decell group (n = 5), using decellularized and recellularized external vessels for anastomosis, and the Bionic group (n = 9), using a vascular prosthesis. Immediate perfusion was achieved in all transplanted constructs. Three animals from the Bionic group completed a 4 week follow-up period. Computed tomography imaging and histopathological analyses demonstrated sustained perfusion of the constructs and progressive development of microvascular structures within the bioprinted tissue over time. These findings demonstrate the feasibility of fabricating and transplanting a perfusable, mechanically stable, bioprinted pancreatic tissue construct capable of supporting in vivo vascular remodeling without a pre-fabricated dense capillary network. This work provides a preclinical proof-of-feasibility for simplified vascular design strategies in bioprinted tissue constructs and supports their further development toward translational applications.
- 4 June 2026
- Published by IOP Publishing in Biofabrication
- Vol. 18 (3) , 035017
Open AccessA Preclinical Large-Animal Evaluation of a 3D Bioprinted Bionic Pancreatic Tissue Model Built on Simplified Vascular Architecture
Three-dimensional (3D) bioprinting enables the fabrication of complex tissue constructs with integrated vascular architectures, offering promising applications in transplantation. It is commonly assumed that dense, pre-formed microvascular networks are required to ensure survival and function of bioprinted organs immediately after implantation. This in vivo study aimed to evaluate the feasibility of bioprinting and transplanting a vascularized pancreatic tissue construct featuring a single perfusable vessel in a porcine model, with a focus on maintaining stable perfusion and supporting post-transplantation microvascular development. The study included 14 pigs, in which a 3D-bioprinted construct was transplanted and connected to the iliac artery or abdominal aorta. Two vascular connection strategies were evaluated: the Decell group (n = 5), using decellularized and recellularized external vessels for anastomosis, and the Bionic group (n = 9), using a vascular prosthesis. Immediate perfusion was achieved in all transplanted constructs. Three animals from the Bionic group completed a 4 week follow-up period. Computed tomography imaging and histopathological analyses demonstrated sustained perfusion of the constructs and progressive development of microvascular structures within the bioprinted tissue over time. These findings demonstrate the feasibility of fabricating and transplanting a perfusable, mechanically stable, bioprinted pancreatic tissue construct capable of supporting in vivo vascular remodeling without a pre-fabricated dense capillary network. This work provides a preclinical proof-of-feasibility for simplified vascular design strategies in bioprinted tissue constructs and supports their further development toward translational applications.
- Open Access
- 20 January 2026
- Published by MDPI AG in Biomolecules
- Vol. 16 (1) , 172
Dependency of Glucose Homeostasis on Pancreatic Enzymes with Special Reference to Amylase; Study on Healthy and Exocrine Pancreatic Insufficient Pigs
We aimed to highlight the roles of the pancreatic enzymes, with special reference to amylase, on glucose homeostasis in healthy pigs and in pigs with exocrine pancreatic insufficiency (EPI). Healthy pigs fed a high-fat diet (HFD) were subjected to mixed meal tolerance tests (MMTTs) and pancreatic enzyme treatments, and then blood glucose and insulin concentrations were determined. Following the development of surgically induced EPI, the same experiment was then repeated on the pigs. A significantly lower net postprandial glycemic response was observed in pigs with EPI compared to healthy pigs. Net postprandial glycemic response was not affected by enzyme supplementation during the MMTTs in healthy pigs, but it was affected by adaptation to macronutrient components of the MMTT test meal, both in healthy and EPI pigs. Net postprandial glycemic response and insulin release curves reached higher levels in Creon-treated EPI pigs compared to amylase-treated EPI pigs. In summary, glucose homeostasis mechanisms in EPI pigs were downregulated compared to healthy animals. Creon supplementation during EPI significantly increased postprandial glucose level, while amylase treatment had the opposite effect, which could be explained by its metabolic actions.
- 20 January 2026
- Published by MDPI AG in Biomolecules
- Vol. 16 (1) , 172
Open AccessDependency of Glucose Homeostasis on Pancreatic Enzymes with Special Reference to Amylase; Study on Healthy and Exocrine Pancreatic Insufficient Pigs
We aimed to highlight the roles of the pancreatic enzymes, with special reference to amylase, on glucose homeostasis in healthy pigs and in pigs with exocrine pancreatic insufficiency (EPI). Healthy pigs fed a high-fat diet (HFD) were subjected to mixed meal tolerance tests (MMTTs) and pancreatic enzyme treatments, and then blood glucose and insulin concentrations were determined. Following the development of surgically induced EPI, the same experiment was then repeated on the pigs. A significantly lower net postprandial glycemic response was observed in pigs with EPI compared to healthy pigs. Net postprandial glycemic response was not affected by enzyme supplementation during the MMTTs in healthy pigs, but it was affected by adaptation to macronutrient components of the MMTT test meal, both in healthy and EPI pigs. Net postprandial glycemic response and insulin release curves reached higher levels in Creon-treated EPI pigs compared to amylase-treated EPI pigs. In summary, glucose homeostasis mechanisms in EPI pigs were downregulated compared to healthy animals. Creon supplementation during EPI significantly increased postprandial glucose level, while amylase treatment had the opposite effect, which could be explained by its metabolic actions.
- 1 January 2026
- Published by Royal Society of Chemistry (RSC) in Food & Function
The neurotrophic effects of selenium and cannabidiol from broiler meat in the rat brain
Bioavailable forms of Se and cannabidiol, used as feed additives for poultry, may induce alterations in the expression of neurotrophins and their receptors in the CNS of an animal model representing a poultry meat consumer.
- 1 January 2026
- Published by Royal Society of Chemistry (RSC) in Food & Function
The neurotrophic effects of selenium and cannabidiol from broiler meat in the rat brain
Bioavailable forms of Se and cannabidiol, used as feed additives for poultry, may induce alterations in the expression of neurotrophins and their receptors in the CNS of an animal model representing a poultry meat consumer.
- Open Access
- 18 September 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (18) , 9115
Efficacy of 2,4-Dinitrobenzenesulfonic Acid (DNBS) in the Maintenance of a Model of Inflammatory Bowel Disease in Pigs (Sus scrofa domestica)
Inflammatory bowel diseases (IBD), such as Crohn’s disease (CD) and ulcerative colitis (UC), are chronic, progressive conditions with increasing prevalence worldwide. The aim of this study was to evaluate the usefulness of a porcine model of colitis induced by 2,4-dinitrobenzenesulfonic acid (DNBS) as a translational model of IBD. Sixteen Polish White pigs were divided into a control group and colitis group. Colitis was induced by rectal administration of DNBS (80 mg/kg in 50% ethanol). Clinical status, hematological and biochemical parameters, fecal calprotectin levels, cytokine plasma concentrations, and histopathological changes in the gastrointestinal tract were evaluated. DNBS administration resulted in persistent diarrhea and mild abdominal pain without general deterioration of health. Significant increases in fecal calprotectin levels and aspartate aminotransferase (AST) activity were observed. Histopathological changes in the colon were limited to the mucosa, which is similar to human UC, while the mild changes observed in the ileum indicate similarity to CD. This model is characterized by moderate inflammation, high reproducibility, and low mortality, making it valuable model in translational research on IBD.
- 18 September 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (18) , 9115
Open AccessEfficacy of 2,4-Dinitrobenzenesulfonic Acid (DNBS) in the Maintenance of a Model of Inflammatory Bowel Disease in Pigs (Sus scrofa domestica)
Inflammatory bowel diseases (IBD), such as Crohn’s disease (CD) and ulcerative colitis (UC), are chronic, progressive conditions with increasing prevalence worldwide. The aim of this study was to evaluate the usefulness of a porcine model of colitis induced by 2,4-dinitrobenzenesulfonic acid (DNBS) as a translational model of IBD. Sixteen Polish White pigs were divided into a control group and colitis group. Colitis was induced by rectal administration of DNBS (80 mg/kg in 50% ethanol). Clinical status, hematological and biochemical parameters, fecal calprotectin levels, cytokine plasma concentrations, and histopathological changes in the gastrointestinal tract were evaluated. DNBS administration resulted in persistent diarrhea and mild abdominal pain without general deterioration of health. Significant increases in fecal calprotectin levels and aspartate aminotransferase (AST) activity were observed. Histopathological changes in the colon were limited to the mucosa, which is similar to human UC, while the mild changes observed in the ileum indicate similarity to CD. This model is characterized by moderate inflammation, high reproducibility, and low mortality, making it valuable model in translational research on IBD.
- Open Access
- 1 August 2025
- Published by MDPI AG in Preprints.org
The Domestic Pig as a Translational Model of Hyperoxaluria: Application to the Study of Oxalate-Dependent Renal Dysfunction
The purpose of this pilot study was to develop and characterize an in vivo porcine model of oxalate-induced renal injury using intravenous infusion of sodium oxalate (NaOx). 2 experimental regimens were developed to replicate acute and chronic hyperoxaluria. In the acute model, 3 different doses of 1% NaOx were administered over 15 hours, resulting in a dose-dependent increase in plasma oxalate concentration (Cmax: 42.4-122.4 µM) and transient hyperoxaluria, with a return to baseline values 6-8 hours after stopping the infusion of NaOx solution. In the chronic model, repeated infusions of NaOx for 7-11 days led to persistent hyperoxalemia (up to 302.4 µM), decreased appetite and increasing renal failure. Histological analysis revealed dose-dependent calcium oxalate (CaOx) deposits in renal tissue (1.85%-9.55% of renal surface area), consistent with moderate to severe nephrocalcinosis. The model represents the key clinical features of both acute kidney injury and the progressive nephrocalcinosis observed in primary hyperoxaluria and oxalaturia. Due to the physiological similarity between pigs and humans, the proposed porcine model is valuable for studying the pathophysiology of oxalate excess and for testing the efficacy of new therapies to counteract its toxicity.
- 1 August 2025
- Published by MDPI AG in Preprints.org
Open AccessThe Domestic Pig as a Translational Model of Hyperoxaluria: Application to the Study of Oxalate-Dependent Renal Dysfunction
The purpose of this pilot study was to develop and characterize an in vivo porcine model of oxalate-induced renal injury using intravenous infusion of sodium oxalate (NaOx). 2 experimental regimens were developed to replicate acute and chronic hyperoxaluria. In the acute model, 3 different doses of 1% NaOx were administered over 15 hours, resulting in a dose-dependent increase in plasma oxalate concentration (Cmax: 42.4-122.4 µM) and transient hyperoxaluria, with a return to baseline values 6-8 hours after stopping the infusion of NaOx solution. In the chronic model, repeated infusions of NaOx for 7-11 days led to persistent hyperoxalemia (up to 302.4 µM), decreased appetite and increasing renal failure. Histological analysis revealed dose-dependent calcium oxalate (CaOx) deposits in renal tissue (1.85%-9.55% of renal surface area), consistent with moderate to severe nephrocalcinosis. The model represents the key clinical features of both acute kidney injury and the progressive nephrocalcinosis observed in primary hyperoxaluria and oxalaturia. Due to the physiological similarity between pigs and humans, the proposed porcine model is valuable for studying the pathophysiology of oxalate excess and for testing the efficacy of new therapies to counteract its toxicity.
- Open Access
- 28 April 2025
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 16, 1529449
Cannabidiol and nano-selenium mediate intestinal barrier function by affecting mucosal microstructures, and gut-associated immunological and oxidative stress response in the gut of chickens infected with C. perfringens
Nutritional additives with biological activity, such as cannabidiol (CBD) and nano-selenium (nano-Se), are viable to prevent bacterial diseases such as necrotic enteritis in chickens. The present study hypothesized that CBD and nano-Se mediate epigenetic and oxidative DNA changes in blood and intestinal epithelial cells and can affect intestinal development and functionality in broiler chickens at an early stage of infection with C. perfringens. This study revealed that both compounds, in combination under physiological or pathophysiological conditions, can act synergistically, improving the indices of histomorphometry of duodenum, jejunum, and ileum. Examination of the structures and ultrastructures of the gastrointestinal tract showed that CBD + nano-Se supplementation did not manifest adverse effects on the host gut indices. In contrast, epigenetic and oxidative markers of blood and gut structures indicated that these components balanced the immune system, mitigating the excessive inflammatory response caused by infection, which boosted the immune response of birds to challenge. There were also significant correlations between indicators of intestinal barrier function, such as diamine oxidase and lactic acid levels, and histomorphometry and markers of DNA integrity in the blood and intestine of chickens. In addition, it was shown that nano-Se increased hemoglobin concentration, which may be beneficial in the host's response to pathogen stimuli. These findings evidenced the health-promoting effect of cannabidiol and nano-selenium in C. perfringens-infected chickens and provided new insights into the mechanism of action of both nutritional additives.
- 28 April 2025
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 16, 1529449
Open AccessCannabidiol and nano-selenium mediate intestinal barrier function by affecting mucosal microstructures, and gut-associated immunological and oxidative stress response in the gut of chickens infected with C. perfringens
Nutritional additives with biological activity, such as cannabidiol (CBD) and nano-selenium (nano-Se), are viable to prevent bacterial diseases such as necrotic enteritis in chickens. The present study hypothesized that CBD and nano-Se mediate epigenetic and oxidative DNA changes in blood and intestinal epithelial cells and can affect intestinal development and functionality in broiler chickens at an early stage of infection with C. perfringens. This study revealed that both compounds, in combination under physiological or pathophysiological conditions, can act synergistically, improving the indices of histomorphometry of duodenum, jejunum, and ileum. Examination of the structures and ultrastructures of the gastrointestinal tract showed that CBD + nano-Se supplementation did not manifest adverse effects on the host gut indices. In contrast, epigenetic and oxidative markers of blood and gut structures indicated that these components balanced the immune system, mitigating the excessive inflammatory response caused by infection, which boosted the immune response of birds to challenge. There were also significant correlations between indicators of intestinal barrier function, such as diamine oxidase and lactic acid levels, and histomorphometry and markers of DNA integrity in the blood and intestine of chickens. In addition, it was shown that nano-Se increased hemoglobin concentration, which may be beneficial in the host's response to pathogen stimuli. These findings evidenced the health-promoting effect of cannabidiol and nano-selenium in C. perfringens-infected chickens and provided new insights into the mechanism of action of both nutritional additives.
- 9 April 2025
- Published by Royal Society of Chemistry (RSC) in Food & Function
- Vol. 16 (9) , 3525-3541
Oral supplementation with Sucrosomial® Iron improves the iron status of preterm piglets delivered by cesarean section
Premature infants are more likely to develop iron deficiency caused by an inadequate iron storage due to shortened pregnancy. Sucrosomial® Iron (SI) is an oral iron formulation of ferric pyrophosphate with high bioavailability and tolerability. This research compared the iron status of preterm and full-term piglets and evaluated the effects of SI on iron homeostasis in the early postnatal period. Eighteen preterm piglets (born via cesarean section on gestation day 109) and twelve full-term piglets (natural birth) were divided into five groups (n = 6 piglets per group): full-term/preterm piglets without iron supplementation, full-term/preterm piglets supplemented with SI (2 mg Fe per piglet per day, days 4–10), and preterm piglets supplemented with ferrous sulfate (2 mg Fe per piglet per day, days 4–10). Samples were collected on day 11. Preterm piglets showed poor growth and low total body iron content, and they developed iron deficiency anemia, as indicated by decreased red blood cell indices and plasma iron parameters. The iron deficiency was partially improved by SI supplementation. Interestingly, higher hepatic and splenic non-heme iron content, accompanied by increased tissue and plasma ferritin, were found in preterm piglets compared to full-term piglets. SI also contributed to tissue iron accumulation in preterm piglets. Functional iron deficiency and iron accumulation in tissues make the regulation of iron metabolism in preterm piglets different from that in full-term ones. SI can alleviate the negative effects of iron imbalances caused by premature birth by regulating the hepcidin–ferroportin axis. In addition, SI did not induce inflammatory or oxidative responses, and its effects are comparable to those of the classic iron supplement, ferrous sulfate. These results indicate that SI is a promising iron supplement for improving the iron status of premature infants.
- 9 April 2025
- Published by Royal Society of Chemistry (RSC) in Food & Function
- Vol. 16 (9) , 3525-3541
Oral supplementation with Sucrosomial® Iron improves the iron status of preterm piglets delivered by cesarean section
Premature infants are more likely to develop iron deficiency caused by an inadequate iron storage due to shortened pregnancy. Sucrosomial® Iron (SI) is an oral iron formulation of ferric pyrophosphate with high bioavailability and tolerability. This research compared the iron status of preterm and full-term piglets and evaluated the effects of SI on iron homeostasis in the early postnatal period. Eighteen preterm piglets (born via cesarean section on gestation day 109) and twelve full-term piglets (natural birth) were divided into five groups (n = 6 piglets per group): full-term/preterm piglets without iron supplementation, full-term/preterm piglets supplemented with SI (2 mg Fe per piglet per day, days 4–10), and preterm piglets supplemented with ferrous sulfate (2 mg Fe per piglet per day, days 4–10). Samples were collected on day 11. Preterm piglets showed poor growth and low total body iron content, and they developed iron deficiency anemia, as indicated by decreased red blood cell indices and plasma iron parameters. The iron deficiency was partially improved by SI supplementation. Interestingly, higher hepatic and splenic non-heme iron content, accompanied by increased tissue and plasma ferritin, were found in preterm piglets compared to full-term piglets. SI also contributed to tissue iron accumulation in preterm piglets. Functional iron deficiency and iron accumulation in tissues make the regulation of iron metabolism in preterm piglets different from that in full-term ones. SI can alleviate the negative effects of iron imbalances caused by premature birth by regulating the hepcidin–ferroportin axis. In addition, SI did not induce inflammatory or oxidative responses, and its effects are comparable to those of the classic iron supplement, ferrous sulfate. These results indicate that SI is a promising iron supplement for improving the iron status of premature infants.